GZMA and peritonitis: Therefore, GzmA−/− mice or mice treated with GzmA inhibitors escape from lethal inflammatory outcomes during acute bacterial infections, causing sepsis or lipopolysaccharide (LPS)-induced peritonitis, leading to systemic inflammation [480,487,488].